castle biosciences stock forecast

How much will Castle Biosciences stock be worth in 2025. We are Repair Biotechnologies a late-stage preclinical-stage biotech company developing several first-in-class therapies based on our innovative Cholesterol Degrading Platform a safe and.


Post Ipo Review Castle Biosciences Grows Despite Pandemic S Effects Ipos On Thestreet U S Ipo Research Opinion

Rooms Rankings Earnings Newsletters Shop.

. The shares were sold at an. CASTLE BIOSCIENCES INC stock price forecast for further price development up to 113 time horizon. About the Castle Biosciences Inc.

Real-time trade and investing ideas on Castle Biosciences Inc CSTL from the largest community of traders and investors. On average Wall Street analysts predict. In other Castle Biosciences news Director Daniel Bradbury sold 7704 shares of the companys stock in a transaction dated Monday August 1st.

The average Castle Biosciences stock price prediction forecasts a potential. CSTL stock returns are also predicted based on historical data. Achieve robust accurate genomic results with minimal turn-around time with Pillars productivity-focused suite of NGS panels and software.

The average price target is 4833 with a high. As of 2022 October 02 Sunday current price of CSTL stock is 26125 and our data indicates that the asset price has been in a. Positive dynamics for Castle Biosciences shares will prevail with possible.

Forecast target price for 09-30-2022. Castle Biosciences stock forecast for 2025 by month. For Castle Biosciences stock forecast for 2025 12 predictions are offered for each month of 2025 with average Castle Biosciences stock forecast of 2588 a high forecast of.

That Castle Biosciencess share price could reach 5350 by Aug 9 2023. The Score for CSTL is 21 which is 58 below its historic median score of 50 and infers higher risk than normal. Based on 3 Wall Street analysts offering 12 month price targets for Castle Biosciences in the last 3 months.

Target levels support and resistance levels. CSTL Stock Price Prediction. Preservation of the entire tumor architecture.

Castle Biosciences Stock Forecast 09-30-2022. Target price in 2023. Castle Biosciences stock price predictions for 2025 using artificial intelligence.

Castle Biosciences CSTL stock consensus. Technical analysis historical chart. Farcasts living human tumor technology harvests fresh human tumors and uses proprietary methods to fragment and culture them ex-vivo.

The current Castle Biosciences CSTL share price is 2202. 1 day and price target of 2405 USD. Castle Biosciences Stock Prediction.

Castle Biosciences Stock Prediction. Find real-time CSTL - Castle Biosciences Inc stock quotes company profile news and forecasts from CNN Business.


Sec Filing Pacbio


Castle Biosciences Inc Cstl Stock Price Last Month


Castle Biosciences Ipo The Buying Opportunity Starts At 3x 3 5x Sales Nasdaq Cstl Seeking Alpha


Castle Biosciences Inks 30m Deal To Acquire Cernostics Shares Rise


Castle Biosciences Inc Cstl Stock Price News Info The Motley Fool


Castle Biosciences Nasdaqgm Cstl Stock Price Quote Analysis Simply Wall St


Cstl Stock Forecast Price News Castle Biosciences


Castle Biosciences Inc Cstl Stock Price Quote News Stock Analysis


Nt10000802x2 Samples Jpg


Alexander Fleming Price Forecasting Models For Castle Biosciences Inc Cstl Stock Paperback Walmart Com


Cstl Castle Biosciences Stock Price


Accolade Nasdaqgs Accd Stock Price Quote Analysis Simply Wall St


Castle Biosciences Stock Forecast Down To 0 000001 Usd Cstl Stock Price Prediction Long Term Short Term Share Revenue Prognosis With Smart Technical Analysis


Castle Biosciences Inc Trade Ideas Nasdaq Cstl Tradingview


Castle Biosciences Share Price Nmq Cstl Stock Research Stockopedia


Castle Biosciences Ipo The Buying Opportunity Starts At 3x 3 5x Sales Nasdaq Cstl Seeking Alpha


Castle Biosciences Inc Nasdaq Cstl Insiders Must Be Happy They Sold Stock As Market Cap Drops To Us 503m Simply Wall St News


Castle Biosciences Inc Cstl Stock Price Quote News Stock Analysis


Castle Biosciences Company Profile Stock Performance Earnings Pitchbook

Iklan Atas Artikel

Iklan Tengah Artikel 1

Iklan Tengah Artikel 2

Iklan Bawah Artikel